BIOMAT Database Logo BIOMAT Database Logo

Phenotypic characterization of three clinical isolates of Burkholderia pseudomallei in Ceará, Brazil. 2006

C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Departamento de Patologia e Medicina Legal, Centro Especializado em Micologia Médica, Universidade Federal do Ceará, 60441-750 Fortaleza, CE, Brazil. camila.virginio@secrel.com.br

Burkholderia pseudomallei, the causative agent of melioidosis was found in a small cluster of cases in Tejuçuoca, Ceará, Brazil. Tests were carried out to determine its phenotypic characteristics: colony morphology on Ashdown agar and MacConkey agar, biochemical profile in conventional biochemical tests and API 20NE, arabinose assimilation and susceptibility testing by disk diffusion, comparing with data in the literature. This study confirms the presence of B. pseudomallei in Brazil and describes its characteristics.

UI MeSH Term Description Entries
D008554 Melioidosis A disease of humans and animals that resembles GLANDERS. It is caused by BURKHOLDERIA PSEUDOMALLEI and may range from a dormant infection to a condition that causes multiple abscesses, PNEUMONIA and BACTEREMIA. Whitmore's Disease,Burkholderia pseudomallei Infection,Burkholderia pseudomallei Infections,Disease, Whitmore's,Infection, Burkholderia pseudomallei,Melioidoses,Whitmore Disease
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D001938 Brazil A country located on the eastern coast of South America, located between Colombia and Peru, that borders the Atlantic Ocean. It is bordered on the north by Venezuela, Guyana, Suriname, and French Guiana, on the south by Uruguay, and on the west by Argentina. The capital is Brasilia.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015373 Bacterial Typing Techniques Procedures for identifying types and strains of bacteria. The most frequently employed typing systems are BACTERIOPHAGE TYPING and SEROTYPING as well as bacteriocin typing and biotyping. Bacteriocin Typing,Biotyping, Bacterial,Typing, Bacterial,Bacterial Biotyping,Bacterial Typing,Bacterial Typing Technic,Bacterial Typing Technics,Bacterial Typing Technique,Technic, Bacterial Typing,Technics, Bacterial Typing,Technique, Bacterial Typing,Techniques, Bacterial Typing,Typing Technic, Bacterial,Typing Technics, Bacterial,Typing Technique, Bacterial,Typing Techniques, Bacterial,Typing, Bacteriocin

Related Publications

C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Environmental isolates of Burkholderia pseudomallei in Ceará State, northeastern Brazil.
February 2009, Applied and environmental microbiology,
C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Burkholderia pseudomallei: a case report of a human infection in Ceará, Brazil.
January 2004, Revista do Instituto de Medicina Tropical de Sao Paulo,
C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Molecular characterization of clinical Burkholderia pseudomallei isolates from India.
July 2011, The American journal of tropical medicine and hygiene,
C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Characterization of ceftazidime resistance mechanisms in clinical isolates of Burkholderia pseudomallei from Australia.
January 2012, PloS one,
C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Trimethoprim/sulfamethoxazole resistance in clinical isolates of Burkholderia pseudomallei.
June 2005, The Journal of antimicrobial chemotherapy,
C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Clinical and environmental isolates of Burkholderia pseudomallei from Brazil: Genotyping and detection of virulence gene.
October 2017, Asian Pacific journal of tropical medicine,
C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains.
April 1997, Epidemiology and infection,
C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Antigenic heterogeneity of lipopolysaccharide among Burkholderia pseudomallei clinical isolates.
January 2000, The Southeast Asian journal of tropical medicine and public health,
C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Burkholderia pseudomallei animal and human isolates from Malaysia exhibit different phenotypic characteristics.
July 2007, Diagnostic microbiology and infectious disease,
C G Virginio, and M F S Teixeira, and C C Frota, and V S Café, and M F G Rocha, and J J C Sidrim
Workflow for Identification of Burkholderia pseudomallei Clinical Isolates in Myanmar.
March 2023, Japanese journal of infectious diseases,
Copied contents to your clipboard!